Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.

ABSTRACT:

SUBMITTER: Kraker RT 

PROVIDER: S-EPMC8377606 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature